在正常血红素水平内的肺移植中国儿童的初始塔克罗利斯剂量优化
Ke Hu1, Su-Mei He2, Cun Zhang3
1Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy & School of Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu, China.
Frontiers in pediatrics
|February 15, 2024
概括
为中国儿科肺移植患者优化塔克罗利斯剂量至关重要. 这项研究提供了基于体重,CYP3A5*1基因型和voriconazole联合使用的具体初始剂量建议,以改善结果.
科学领域:
- 儿科移植 儿科移植
- 药理动力学 药理动力学
- 免疫抑制管理的管理.
背景情况:
- 对于中国儿科肺移植接受者,正常血红素的初始塔克罗利斯剂量没有很好地定义.
- 确定最佳的初始塔克罗利斯剂量对于有效的免疫抑制和患者的治疗结果至关重要.
研究的目的:
- 为了优化中国儿科肺移植患者的初始塔克罗利斯剂量,这些患者血红素水平正常.
- 为这个特定的患者群体提供基于证据的剂量指南.
主要方法:
- 在肺移植患者中使用了一种已发表的塔克罗利斯人群药动力学模型.
- 采用蒙特卡洛模拟来确定最佳的初始塔克罗利斯剂量.
- 在模拟中考虑患者的体重,CYP3A5*1基因型和voriconazole的同时使用.
主要成果:
- 提供了具体的塔克罗利斯剂量建议 (mg/kg/天,分为两个剂量),按体重类别 (10-40公斤) 分层.
- 剂量因CYP3A5*1基因型存在和同时使用沃里可纳而有所不同.
- 例如,没有伏利可纳的非载体:0.02毫克/公斤/天 (10-32公斤) 和0.03毫克/公斤/天 (32-40公斤).
结论:
- 这项研究首次优化了中国儿科肺移植患者的初始塔克罗利斯剂量,其血液度正常.
- 这些发现为临床医生提供了关键的指导,以在这个脆弱人群中个性化塔克罗利斯治疗.
更多相关视频
相关概念视频
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...


